The last week of 2022, Mexico began the application day of Cuban Abdala vaccines under the booster scheme. Of the 4,000,000 doses that were available up to that moment, only a little over 6,000since distrust prevails among the population despite the increase in new infections that was registered on December 27 36,181 cases.
“It is not to be given to children, it must be given to adults,” said the former Health Commissioner who dealt with the Influenza A (H1N1) pandemic in Mexico from 2009 to 2010. Abdala is “a vaccine that has an original sin because without Having a phase three study began to be implemented massively in Cuba, in more than 1,000,000 people. It has not been studied as a revaccination either.” The specialist said that the Cuban dose “seems” safe and effective.
“You have to understand that in a clinical trial they can include 2,000, 20,000 or 50,000 people, but in the open population it has not yet been experienced between hundreds and millions” of people, shared on their social media Laurie Ann Ximénez-Fyvie, doctor of medical sciences with a specialization in microbiology. The problem with Abdala is that there is not “sufficient information” about its effectiveness as a booster.
The Abdala vaccine, of which Mexico bought 9,000,000 million doses from the Government of Cuba, does not have studies that certify it “as a reinforcement” against covid-19
The Abdala vaccine, which Mexico bought from the Government of Cuba 9,000,000 million dosesIt does not have the endorsement of the World Health Organization (WHO) or studies that certify it “as reinforcement” against covid-19. The infectologist and National Health Award 2020, Francisco Moreno Sánchez, stressed that the effectiveness of the island’s antidotes against the new variants of the coronavirus is not known either.
The Secretary of Health of Mexico City, Oliva López, attributed the low influx in vaccination units to the year-end parties. confirmed to the newspaper Millennium that this immune system is “the only one available as a booster” for people 18 years of age and older, although he also acknowledged that the doses purchased from the Island are “much more focused on the original forms of the virus,” but practically the majority of the vaccines have with the technology to deal with the coronavirus.
Despite the optimism of the López health company, in Matamoros (Tamaulipas), another of the states with little interest from people in vaccinating with Abdala, the head of the VI health jurisdiction, Juan Pérez, specified to Millenniumthat the doses available are “to start schemes, it is not a booster, and it is for people over 18 years of age”.
The study Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort studypublished in the scientific journal The Lancentreveals an efficacy of 92.3% of the drug.
Dr. Moreno Sánchez was direct on his social networks about the doses developed against the coronavirus on the island and that it has marketed with Venezuela, Nicaragua, Vietnam and elaborates with Tehran. “For consistency, I would not apply it to myself, nor to my family. A vaccine that is not approved by the WHO does not have the scientific support to recommend it.”
“Abdala contains aluminum hydroxide as an adjuvant, which is not done for other vaccines against covid-19, since its efficacy decreases,” Moreno Sánchez said on his social networks.
The specialist mentioned that “we are no longer at the stage where there were no vaccines, that has already happened. Now we know that there are better, more up-to-date vaccines and the decision was simply made to apply this vaccine for political purposes. Health, safety and efficacy do not mattered in the decision.”
________________________
Collaborate with our work:
The team of 14ymedio He is committed to doing serious journalism that reflects the reality of deep Cuba. Thank you for accompanying us on this long road. We invite you to continue supporting us, but this time becoming a member of our newspaper. Together we can continue transforming journalism in Cuba.
